Literature DB >> 10950393

Plasma renin activity in the emergency department and its independent association with acute myocardial infarction.

J D Blumenfeld1, J E Sealey, M H Alderman, H Cohen, R Lappin, D F Catanzaro, J H Laragh.   

Abstract

Elevated plasma renin activity (PRA) is associated with increased risk of future myocardial infarction (MI) in ambulatory hypertensive patients. The present study evaluated the relationship of PRA to the diagnosis of acute MI in patients presenting to an emergency department with suspected acute MI. PRA was measured upon entry to the emergency department, before any acute treatment, as part of the standard evaluation of 349 consecutive patients who were hospitalized for suspected MI. Diagnosis of acute MI was confirmed in 73 patients, and ruled out in 276. They did not differ in age (65.9 +/- 2 v 66.1 +/- 1 years), systolic (143 +/- 4 v 140 +/- 2 mm Hg), or diastolic (81 +/- 2 v 81 +/- 1 mm Hg) pressures. Median PRA was 2.7-fold higher in acute MI (0.89 v 0.33 ng/L/s; P < .001). In a multivariate analysis controlling for other cardiac risk factors and prior drug therapy, PRA as a continuous variable was the predominant independent factor associated with acute MI (P < .0001), followed by white race (P = .002) and history of hypertension (P = .047). The height of the PRA level upon entry to the emergency department was directly and independently associated with the diagnosis of acute MI. These new findings extend earlier reports because they encompass acute MI patients, include both hypertensive and normotensive patients, and control for potentially confounding variables. Based on these observations, a randomized clinical trial is warranted to determine whether measurement of PRA in acute MI could refine the process by which treatments are applied.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10950393     DOI: 10.1016/s0895-7061(00)00277-6

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  8 in total

1.  Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization.

Authors:  Shinji Hisatake; Shunsuke Kiuchi; Takayuki Kabuki; Takashi Oka; Shintaro Dobashi; Takanori Ikeda
Journal:  Heart Vessels       Date:  2016-07-15       Impact factor: 2.037

2.  Plasma renin activity and its association with ischemic heart disease, congestive heart failure, and cerebrovascular disease in a large hypertensive cohort.

Authors:  John J Sim; Jiaxiao Shi; Rushdy Al-Moomen; Hind Behayaa; Kamyar Kalantar-Zadeh; Steven J Jacobsen
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-09-25       Impact factor: 3.738

Review 3.  Direct renin inhibitors: a new approach to antihypertensive drug treatment.

Authors:  C Venkata S Ram
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-08       Impact factor: 3.738

4.  Protective effects of angiotensin-converting enzyme inhibitors in high-risk African American men with coronary heart disease.

Authors:  Vasilios Papademetriou; Christodoulos Kaoutzanis; Michael Dumas; Andreas Pittaras; Charles Faselis; Peter Kokkinos; Ross D Fletcher
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-11       Impact factor: 3.738

Review 5.  Past, Present, and Future of Blood Biomarkers for the Diagnosis of Acute Myocardial Infarction-Promises and Challenges.

Authors:  Ioan Tilea; Andreea Varga; Razvan Constantin Serban
Journal:  Diagnostics (Basel)       Date:  2021-05-15

6.  John H. Laragh, MD: clinician-scientist.

Authors:  Jean E Sealey
Journal:  Am J Hypertens       Date:  2014-08       Impact factor: 2.689

7.  Plasma renin activity and risk of cardiovascular and mortality outcomes among individuals with elevated and nonelevated blood pressure.

Authors:  Simran K Bhandari; Michael Batech; Jiaxiao Shi; Steven J Jacobsen; John J Sim
Journal:  Kidney Res Clin Pract       Date:  2016-07-26

8.  Blockade of the renin-angiotensin system in African Americans with hypertension and cardiovascular disease.

Authors:  Elijah Saunders; James R Gavin
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jan-Feb       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.